Medical Advocates
Fusion (Entry) Inhibitors
  Main Page

 New and Noteworthy   
Resistance
Guidelines






 		  
HIV Main Page Main New/Newsworthy Home Page
Last Update:  October 18, 2008
Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
New and Noteworthy
       
July 2008
 
  Serious infection from Staphylococcus aureus in 2 HIV-infected patients receiving fusion inhibitor therapy.
Gaughan EM, Ritter ML, Kumar PN, Timpone JG.
 AIDS Read. 2008 May;18(5):266-8.
Abstract
General Reports
 
     Journal Papers, Abstracts, and Commentaries
 
 
Development of HIV fusion inhibitors
Schneider SE, Bray BL, Mader CJ. et al
 J Pept Sci. 2005 Aug 30;
 Abstract

FULL-TEXT PDF ARTICLE
 Entry Inhibitors: A Primer on the Class and on its Most Promising Agents
 Shepherd JC,  Quinn TC,    
The Hopkins HIV Report, July  2004 Vol 16. No 4
 Paper
Pharmacokinetics
 
Efficacy
 
   
Adverse Events
 
   
Viral Dynamics Data
 
Resistance Data
 

    Conference Reports, Abstracts, and Posters

  CONFERENCE PDF POSTER
Quantitative assessment of resistance to fusion inhibitors in a replicative Phenotyping assay.
V Brondani, F Hamy, T  Klimkait
 Poster
Clinical Management
 

     Journal Papers, Abstracts, and Commentaries

  Clinical perspective of fusion inhibitors for treatment of HIV.
 Rockstroh JK, Mauss S.
 J Antimicrob Chemother. 2004 Mar 24
Abstract
Guidelines
 

     Journal Papers, Abstracts, and Commentaries

  FULL-TEXT PDF ARTICLE
 Guidelines for using antiretroviral agents among HIV-infected adults and adolescents.
Recommendations of the Panel on Clinical Practices for Treatment of HIV.
 MMWR Morb Mortal Wkly Rep. 2002 May 17;51(RR-7):1-55.
 Paper
Pregnancy/Perinatal Data
 

     Journal Papers, Abstracts, and Commentaries
Pediatric Data
 

 

HIV Main Page Main New/Newsworthy Home Page

Fusion Inhibitors